Status:
RECRUITING
Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
Lead Sponsor:
University of Arizona
Collaborating Sponsors:
Transdermal Cap, Inc.
Conditions:
Androgenetic Alopecia
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medicat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 25 years and older
- Men and women with AGA, untreated or with 6-month washout of previous treatments
- Men: Norwood stage IIa - V
- Women: Ludwig I-1 - II-2, or frontal pattern
- All patients: Fitzpatrick skin types I to IV
- Exclusion criteria:
- Men: Norwood stage Va, VI, VII
- Women: Ludwig stage III, advanced
- All patients: Fitzpatrick skin types V, VI
- Current use or within the past six month of other treatment for AGA, including topical and oral minoxidil, topical and oral finasteride and dutasteride
- Age 0-25 years
Exclusion
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05365360
Start Date
June 1 2022
End Date
May 1 2025
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner University Dermatology
Tucson, Arizona, United States, 85719